April 22nd, 2023

Journal of Clinical Pathology

J Clin Pathol. 2018 Jul; 71(7): 579–583.
Published online 2018 Mar 28. doi: 10.1136/jclinpath-2018-205071

PMCID: PMC6204964
PMID: 29593061

Biomarkers of chondrosarcoma Wonju Jeong1 and Ha-Jeong…

April 11th, 2023

The INBRX 109 Clinical Trials will shortly resume recruiting patients for their Phase 2 Clinical Trial treating patients with Conventional Chondrosarcoma with recurrence or metastasis. Listed below is a response from Inhibrx:

We have just released…

April 7th, 2023

The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, a little over one month ago. The registry currently has 60 participants. We want to encourage everyone in the community to…

March 29th, 2023

Antoine Gilbert 1, Mihaela Tudor 2,3, Juliette Montanari 1, Kevin Commenchail 1 , Diana Iulia Savu 2 ,Paul Lesueur 4,5,6 and François Chevalier 1,*

Simple Summary: This review article aims in describing the origins of chondrosarcoma…

March 23rd, 2023

Some of you may not know who Amber Sarcone is. In Philly, she’s a part of the royal family. Her family runs Sarcone’s Bakery, makers of some of the most delicious damn bread you’ll ever have the pleasure of shoving into your mouth. Her cousin is…

March 16th, 2023

A research team led by Dr Darrell Green, a trustee of the Bone Cancer Research Trust, have identified a new drug that works against all main forms of bone cancer.

Researchers at the University of East Anglia discovered that the drug, called…

March 15th, 2023

The Chondrosarcoma Foundation in partnership with the National Organization for Rare Disorders (NORD®) has launched the Chondrosarcoma Patient Registry. The patient registry creates a platform for patients around the world to strengthen their…

March 5th, 2023

The Chondrosarcoma Foundation is developing a Patient / Family/ Caregiver Advisory Board in the effort to create a voice for chondrosarcoma patient’s and caretakers to address concerns and advocate for effective treatment and quality care.

The…

March 2nd, 2023

The Chondrosarcoma Foundation in partnership with the National Organization for Rare Disorders (NORD®) has launched the Chondrosarcoma Patient Registry. Chondrosarcoma is a rare bone cancer that currently has no cure. Its prevalence and origin are…

February 24th, 2023

The time has come to make rare diseases a national public health imperative For decades, the rare disease community has been striving for greater recognition and scientific breakthroughs addressing the unmet medical needs millions of Americans face…